| scholarly article | Q13442814 |
| P50 | author | Anshuman Panda | Q49956499 |
| Samuel J Lee | Q60396132 | ||
| W. Kimryn Rathmell | Q90348778 | ||
| P2093 | author name string | Gyan Bhanot | |
| Shridar Ganesan | |||
| Ronald Swanstrom | |||
| Joel S Parker | |||
| Eric M Wallen | |||
| Matthew I Milowsky | |||
| Kathryn E Beckermann | |||
| Jonathan S Serody | |||
| William Y Kim | |||
| Dante S Bortone | |||
| Sara R Selitsky | |||
| Lisa M Bixby | |||
| Benjamin G Vincent | |||
| Aguirre A De Cubas | |||
| Christof C Smith | |||
| P2860 | cites work | HERVd: the Human Endogenous RetroViruses Database: update | Q22330793 |
| The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences | Q24606140 | ||
| TranspoGene and microTranspoGene: transposed elements influence on the transcriptome of seven vertebrates and invertebrates | Q24649774 | ||
| Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells | Q24657020 | ||
| Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas | Q24677052 | ||
| More tricks with tetramers: a practical guide to staining T cells with peptide-MHC multimers | Q26864749 | ||
| The Sequence Alignment/Map format and SAMtools | Q27860966 | ||
| Phenotypic analysis of antigen-specific T lymphocytes | Q28290058 | ||
| The evolutionary dynamics of endogenous retroviruses | Q47612048 | ||
| NetMHCpan-4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data | Q47696633 | ||
| MiXCR: software for comprehensive adaptive immunity profiling. | Q48193977 | ||
| msa: an R package for multiple sequence alignment | Q50862023 | ||
| Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer | Q50906889 | ||
| Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer | Q51782974 | ||
| An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics | Q52602395 | ||
| Design and use of conditional MHC class I ligands | Q53637625 | ||
| Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. | Q54618275 | ||
| Generation of peptide–MHC class I complexes through UV-mediated ligand exchange | Q60634999 | ||
| Detecting the expression of human endogenous retrovirus E envelope transcripts in human prostate adenocarcinoma | Q73589680 | ||
| Expression of human endogenous retrovirus k envelope transcripts in human breast cancer | Q74033989 | ||
| Synthetic peptides as antigens for antibody production | Q81135310 | ||
| Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 | Q29547403 | ||
| STAR: ultrafast universal RNA-seq aligner | Q29615052 | ||
| Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer | Q29619481 | ||
| Differential expression analysis of human endogenous retroviruses based on ENCODE RNA-seq data | Q31016167 | ||
| Cell-type specific gene expression profiles of leukocytes in human peripheral blood | Q33243638 | ||
| EnHERV: Enrichment analysis of specific human endogenous retrovirus patterns and their neighboring genes | Q33638169 | ||
| Prognostic B-cell signatures using mRNA-seq in patients with subtype-specific breast and ovarian cancer | Q33916814 | ||
| Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease | Q34274473 | ||
| A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia | Q34274580 | ||
| Neoantigens in cancer immunotherapy. | Q34470074 | ||
| The evolutionary dynamics of human endogenous retroviral families | Q34530194 | ||
| Molecular signatures database (MSigDB) 3.0. | Q35019708 | ||
| Inactivation of the von Hippel–Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer | Q35179504 | ||
| EAU guidelines on renal cell carcinoma: 2014 update. | Q35548292 | ||
| Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses | Q36015063 | ||
| Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells | Q36471611 | ||
| Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7 | Q36499204 | ||
| DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas | Q36620357 | ||
| Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma | Q36730827 | ||
| Mutant MHC class II epitopes drive therapeutic immune responses to cancer | Q36817092 | ||
| Molecular and genetic properties of tumors associated with local immune cytolytic activity | Q36869059 | ||
| Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer | Q36898870 | ||
| Detection of an Immunogenic HERV-E Envelope with Selective Expression in Clear Cell Kidney Cancer | Q36918135 | ||
| GWIPS-viz: development of a ribo-seq genome browser | Q37661931 | ||
| An immunogenic personal neoantigen vaccine for patients with melanoma | Q38692859 | ||
| Tumour-specific proline vulnerability uncovered by differential ribosome codon reading. | Q38794075 | ||
| Salmon provides fast and bias-aware quantification of transcript expression | Q38926825 | ||
| Immune targets and neoantigens for cancer immunotherapy and precision medicine | Q39057617 | ||
| HERVd: database of human endogenous retroviruses | Q39524490 | ||
| Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types | Q39661584 | ||
| Regulation of human endogenous retrovirus-K expression in melanomas by CpG methylation | Q39749080 | ||
| CDK4/6 inhibition triggers anti-tumour immunity. | Q40081387 | ||
| Expression of human endogenous retrovirus K in melanomas and melanoma cell lines | Q40421149 | ||
| CpG methylation directly regulates transcriptional activity of the human endogenous retrovirus family HERV-K(HML-2) | Q40478183 | ||
| Classification and characterization of human endogenous retroviruses; mosaic forms are common | Q40821426 | ||
| Claudin-low bladder tumors are immune infiltrated and actively immune suppressed | Q41160701 | ||
| Retrovirus-like particles from the human T47D cell line are related to mouse mammary tumour virus and are of human endogenous origin | Q41626763 | ||
| Human endogenous retrovirus HERV-K113 is capable of producing intact viral particles | Q42030768 | ||
| Erratum to: Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures | Q42318892 | ||
| Role of DNA methylation in transcription of human endogenous retrovirus in the pathogenesis of systemic lupus erythematosus | Q44103565 | ||
| P433 | issue | 11 | |
| P921 | main subject | immunotherapy | Q1427096 |
| P304 | page(s) | 4804-4820 | |
| P577 | publication date | 2018-10-02 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma. | |
| P478 | volume | 128 |
| Q91666603 | Alternative tumour-specific antigens |
| Q89855466 | Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy |
| Q64059147 | Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs |
| Q90629204 | Consensus guidelines for the definition, detection and interpretation of immunogenic cell death |
| Q101216389 | Defining the clinical genomic landscape for real-world precision oncology |
| Q90192573 | Dynamic Signatures of the Epigenome: Friend or Foe? |
| Q91361596 | Epigenetic therapy in immune-oncology |
| Q99616989 | Functional genomic landscape of cancer-intrinsic evasion of killing by T cells |
| Q90189900 | Human Endogenous Retroviruses (HERVs): Shaping the Innate Immune Response in Cancers |
| Q98612837 | Human Endogenous Retroviruses in Clear Cell Renal Cell Carcinoma: Biological Functions and Clinical Values |
| Q100739232 | Immune responses in genomically simple SWI/SNF-deficient cancers |
| Q96023037 | Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma |
| Q90182325 | LTR retroelement expansion of the human cancer transcriptome and immunopeptidome revealed by de novo transcript assembly |
| Q90083168 | Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes |
| Q99630568 | Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors |
| Q91393992 | Retroviral signature can predict therapy outcome |
| Q100455154 | Targeting the HIF2-VEGF axis in renal cell carcinoma |
| Q91520697 | The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy |
| Q89556854 | The landscape of viral associations in human cancers |
| Q64275331 | Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop |
| Q91344553 | Transposable element expression in tumors is associated with immune infiltration and increased antigenicity |
| Q94450977 | Widespread and tissue-specific expression of endogenous retroelements in human somatic tissues |
Search more.